8th Berlin Conference on IP in Life Sciences

                           Natural Products

Natural products are an important source for pharmaceuticals, food ingredients, cosmetics and other functional admixtures. More than 1000 compounds alone have been taken from plants, animals or other marine resources for medicinal, nutritional and cosmetic use. However, progress in the life sciences opened the stage for a new generation of natural compounds: DNA sequences from terrestrial and aquatic resources like plants, animals or microbial organisms led to recombinant proteins with uncomparable properties.

But the access to natural products is contested. The Nagoya Protocol and the Convention on Biological Diversity regulate the access, although these conventions have yet to be implemented in the EU and national law. This process is still ongoing and touches issues such as biodiversity, better conservation, more sustainable use of marine biodiversity and the enhancement of cooperation and synergy between providers of biodiversity and their industrial users. This is highly critical for countries exhibiting a rich biodiversity to create new added value on a global scale. The regulations will have an impact on the patenting system. This BIOCOM conference addressed the latest regulations and illustrated the practical use.

Programme

Time

Title

Speaker

Download

9.30

Welcome Address

H.E. Rev. Makhenkesi Stofile, Ambassador of the Republic of South Africa

CV

9.45

Natural Compounds – Business Potentials

Dr. Guy Carter, former Director
Wyeth Natural Products Division, USA

CV
PPT

 

Strategic Value of the Bioeconomy for Emerging Countries

Glaudina Loots, Director Health Innovation, Department of Science and technology, ZA

CV
PPT

 

Access and Benefit-sharing – Understanding the International Legal Framework

Thomas Greiber, Research Associate
Institute for Advanced Sustainability Studies e.V, GER

CV
PPT

11:00 – 11:30

Coffee Break

 

 

 11:30

Patents: Milestone Patent Cases in the Field of Natural Compounds

Dr. Jürgen Meier, Partner 

Vossius & Partner, GER

CV
PPT

 

US IP Protection of Natural Products: How Now?

Dr. Michele Wales, Founder and Principal, InHouse Patent Counsel LLC, USA

CV
PPT

 

Nagoya, Natural Products and Patenting: The International IP Issues

Wend Wendland, Director, Traditional Knowledge Division, World Intellectual Property Organisation

CV
PPT

13:00 – 14:00

Lunch

 

 

14:00

Implementation of the Nagoya Protocol in Europe – Challenge or Business Opportunity

Elise Melon, Manager Intellectual Property & Trade, EFPIA, BE

CV
PPT

 

From Traditional Medicine to Modern Drug Discovery

 

Dr. Christian Haug, Managing Director Bicoll GmbH, GER

CV
PPT

 

Research: From Collection to Business Case

Thomas Vanagt, Founder and Director eCoast Marine Research, BE

CV
PPT

15:15 – 15:45

Coffee Break

 

 

15:45

Natural Products Research: African Medicinal Plants with Anti-Diabetic Potential

Dr. Shahidul Islam, Senior Lecturer of Biochemistry, University of KwaZulu-Natal, ZA

CV
PPT

 

Natural Products and Antibiotics – Research Alliances

Prof. Dr. Jochen Maas, Managing Director, Sanofi-Aventis Deutschland GmbH, GER

CV
PPT

 

Natural Compounds 2.0 – opportunities and legal aspects

Neil Goldsmith, CEO
Evolva AG, CH

CV
PPT

17:00

Discussion/Wrap up

 

 

17:15

Reception and Networking

 

 

   

When & where

When: 27 February 2015

Where: Embassy of South Africa
Tiergartenstr. 18
10785 Berlin, Germany

Directions

Sponsors

 

Supporting Partners

Media Partners

CONTACT & INFORMATION

 

 

Uta Holmer

Dipl.-Volkswirtin

Veranstaltungsmanagement

 

 

Telefon: +49-30-264921-53

events[at]biocom.de